Vendredi 29 Mai 2015
- Steven Taub, Research and Development Manager, Cardiovascular Surgery Department, Centre Hospitalier Universitaire Vaudois, CHUV, Lausanne.
- "Biotherapeutic Immunomodulation as a Countermeasure to Hyperinflammatory Tissue Damage - A Double-Blind, Phase 1 Human Study of Osteoarthritis, with Surprising Efficacy".
- Summary: may2015_taub_summary.pdf
- Presentation: may2015_taub_presentation.pdf
- Paper Mahmoud FF et al 2014: mahmoud-haines-awadi_osteoarthritis-biotherapeutic_nov_2014_online.pdf